期刊文献+

Rho激酶抑制剂与心力衰竭关系的研究进展 被引量:7

Advances in Relationship Between Rho-kinase Inhibitors and Heart Failure
下载PDF
导出
摘要 Rho激酶抑制剂通过抑制钙敏化效应,抑制炎细胞的迁移和浸润,增加内皮型一氧化氮合成酶的表达等机制扩张冠状动脉血管,减少炎症介质的产生,促进一氧化氮生成,保护损伤心肌组织,抑制心室重构,从而达到改善心力衰竭的作用。现简要心力衰竭与Rho激酶抑制剂关系的研究进展。 Rho-kinase inhibitors to restrain calcium sensitization effect, migration and infiltration of inflammatory cell, raise nitric oxide synthetase, expression and so on, achieve expand coronary artery, and decrease product inflammation, enhance nitric oxide production, protect injury cardiac muscle, inhibitor ventricles, reconstruction, achieve the improvement of heart failure. This article reviews the advancement of relation of Rho-kinase inhibitors and heart failure.
出处 《心血管病学进展》 CAS 2009年第4期673-676,共4页 Advances in Cardiovascular Diseases
基金 黑龙江省科技厅国际合作重点项目(WB07C01)
关键词 心力衰竭 RHO激酶 RHO激酶抑制剂 heart failure Rho-kinase Rho-kinase inhibitors
  • 相关文献

参考文献29

  • 1Leung T,Manser E,Tan L,et al.A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes[J].J Biol Chem,1995,270(49):29051-29054.
  • 2Funakoshi Y,Ichiki T,Shinokawa H,et al.Rho-kinase mediates angiotensionⅡ-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells[J].Hypertension,2001,38(10):100-104.
  • 3Takeda K,Ichiki T,Tokunou T,et al.Critical role of Rho-kinase and MEK/ERK pathways for angiotensinⅡ induced plasminogen activator inhibitor type-4 gene expression[J].Arterioscler Thromb Vasc Biol,2001,21(5):868-873.
  • 4Sauzeau V,le Mellbnnec E,Bertoglio J,et al.Human urotensinⅡ-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase[J].Circ Res,2001,88(11):1102-1104.
  • 5Madaule P,Axel R.A novel ras-related gene family[J].Cell,1985,41(1):31-40.
  • 6Fukata Y.Rho-Rho-kinase pathway in smooth muscle contraction and cytokeletal reorganization of non-muscle cells[J].Trends Pharmacol Sci,2001,22(1):32-39.
  • 7Kuroda S,Amano M.Regulation of the cytoskeleton and cell adhesion by the Rho family GTPase in mammalian cell[J].Ann Rev Biochem,1999,68:459-468.
  • 8Matsui T,Amano M,Yananoto T,et al.Rho-associated kinase,a novel serine/ threonine kinase,as a putative target for small GTP binding protein Rho[J].EMBO,1996,15(9):2208-2216.
  • 9Solaro R Jr.Myosin light chain phosphatase[J].Circ Res,2000,87930:173-175.
  • 10Riento K,Ridley AJ.Rocks:multifunctional kinases in cell behaviour[J].Nat Rev Mol Cell Biol,2003,4(6):446-456.

二级参考文献47

  • 1Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329.
  • 2Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646.
  • 3Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805.
  • 4Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249.
  • 5Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175.
  • 6Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327.
  • 7Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564.
  • 8Becker R,Merkely B,Bauer A,et al.Ventricular arrhythmias induced by endothelin-1 or by acute ischemia: a comparative analysis using three-dimensional mapping[J]. Cardiovascular Research, 2000,45(2):310-320.
  • 9Antonio M,Aguilara A,Reverta F,et al.Ntravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion[J]. General Pharmacology, 2000,35(3):143-147.
  • 10Wang X W, Masato O,Atsuyuki W, et al. Endothelin-1 promotes vascular structural remodeling during the progression of heart failure: Prevention of vascular remodeling using a specific endothelin-converting enzyme inhibitor[J]. Life Science ,2001, 69(21):2477-2488.

共引文献54

同被引文献110

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部